Official UK procurement notice
Botulinum Antitoxin Heptavalent (2026)
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought
Published requirement descriptionThe supply of Botulinum Antitoxin Heptavalent
- How the procedure runs: 1. Single Submission Stage – Full Tender Evaluation Suppliers will be invited to submit full and final tenders at the initial stage. Submissions must comprehensively address: • Technical Requirements: Including delivery schedules, product quality, risk management, and social value commitments. • Commercial Requirements: Including pricing, shelf-life guarantees, business continuity provisions, and contractual flexibility. 2. Optional Negotiation Stage – Risk Mitigation & Value Optimisation Following evaluation, the Authority reserves the right to: • Directly award to the highest scoring tender if it meets all critical success criteria. • Or, initiate a single negotiation round with one or both suppliers to refine specific elements of their proposals, where clarification or enhancement is required to meet operational or strategic needs.
CPV: Pharmaceutical products
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£1
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (3)
- Technical - Risk: 10%
- Commercial: 80%
- Social Value: 10%
Published award criteria (3)
- Social Value
- Commercial
- Technical - Risk
- Price carries 80 of 100 points: a 10% discount moves about 8 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Competitive flexible procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 26 Jun 2026, 12:27 BST
- Last source update
- 26 Oct 2026, 15:36 GMT
- Award evaluation window
- Submission end – 30 Sept 2026
- Authority reference
C459163- FTS notice number
2026/S 000-066675- Latest notice
- Contract award notice (UK6)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06be1bFind a Tender
- How it runs
- Single Submission Stage – Full Tender Evaluation
Suppliers will be invited to submit full and final tenders at the initial stage. Submissions must comprehensively address:
- Technical Requirements: Including delivery schedules, product quality, risk management, and social value commitments.
- Commercial Requirements: Including pricing, shelf-life guarantees, business continuity provisions, and contractual flexibility.
- Optional Negotiation Stage – Risk Mitigation & Value Optimisation
Following evaluation, the Authority reserves the right to:
- Directly award to the highest scoring tender if it meets all critical success criteria.
- Or, initiate a single negotiation round with one or both suppliers to refine specific elements of their proposals, where clarification or enhancement is required to meet operational or strategic needs.
- Risks
Compliant licensing required.
How it was run
Official notice- Submission deadline
- 13 Aug 2026, 17:00 BST
- Clarification deadline
- 30 Jul 2026, 12:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
UKHSA are carrying out a competitive flexible competition for the provision of Botulinum Antitoxin Heptavalent.
As part of this requirement, UKHSA requires all tenderers to sign a Non-Disclosure Agreement before being given access to the tender documents. A copy of our Non-Disclosure Agreement is available in the Documents section.
Please complete and electronically sign and return to UKHSA through the Atamis messaging system.
The full ITT and specification will be released to tenderers who have a fully signed NDA, through a separate Atamis project.
The tender submission deadline is Thursday 13th August. Tenderers are therefore encouraged to complete and return the NDA as early as possible to allow sufficient time to access the tender documents and prepare and submit a compliant bid.
If there are any questions, please ask through the Atamis messaging system.
Timeline
26 Jun 2026 → 5 Nov 2026 · 11 dates- Planning notice published122 days ago26 Jun 2026, 12:27 BST
- Market engagement108 days ago10 Jul 2026, 23:59 BST
Suppliers are invited to submit responses including the following:
Product Information:
- Product name and description
- Available dose/pack sizes and formats
- Any minimum order quantities
Lead Times and Supply:
- Standard lead times based on contract starting September 2026
If your organisation is interested in this requirement, please provide the above information to [email protected] by COP 10th July 2026.
Once the tender is published, bidders will be required to sign a Non-Disclosure Agreement (NDA) prior to gaining access to the tender documentation.
- Tender notice published103 days ago15 Jul 2026, 11:45 BST
- Next notice expected101 days ago17 Jul 2026, 23:59 BST
- Clarification questions by88 days ago30 Jul 2026, 12:00 BST
- Submission deadline74 days ago13 Aug 2026, 17:00 BST
- Award decision expected by26 days ago30 Sept 2026, 23:59 BST
- Contract starts22 days ago5 Oct 2026, 00:00 BST
- Assessment summaries sent24h ago26 Oct 2026
- Latest notice published9h ago26 Oct 2026, 15:36 GMT
- Today27 Oct 2026
- Standstill endsin 9 days5 Nov 2026, 23:59 GMT
Notice history
8 events · 3 releases on Find a Tender · since 26 Jun 2026- Preliminary market engagement notice published26 Jun 2026, 12:27 BSTUK2
- Tender notice published15 Jul 2026, 11:45 BSTUK4
- Status changed to active15 Jul 2026, 11:45 BST
- Procurement method changed15 Jul 2026, 11:45 BST
- Deadline published: 13 Aug 2026, 17:00 BST15 Jul 2026, 11:45 BST
- Contract award notice published26 Oct 2026, 15:36 GMTUK6
- Status changed to complete26 Oct 2026, 15:36 GMT
- Contract signature expected11 Nov 2026, 23:59 GMTscheduled
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Emergent BioSolutions Canada Inc16 Nov 2026 – 15 Nov 2028 · up to 15 Nov 2030Extensions: 1+1 | £1 | 26 Oct 2026standstill to 5 Nov 2026 | Standstill |
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1final-stage tenders | 0 | 0 | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Emergent BioSolutions Canada IncAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender